Xianglin Zuo

5PUBLICATIONS
26CO-AUTHORS
Molecular targetsGenomics and transcriptomicsBiomaterialsPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 23, 2026
Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies.

|Sep 09, 2025
1p-Enh-regulated CYP4B1 alleviates NNK-induced heart failure and lung cancer via the STAT3 pathway.

Li Dai, Jun Hu, Ye Yang

|May 07, 2025
Breakthroughs and challenges of organoid models for assessing cancer immunotherapy: a cutting-edge tool for advancing personalised treatments.

Qian Wang, Fangwei Yuan, Xianglin Zuo

|Dec 04, 2023
TNFRSF19 within the 13q12.12 Risk Locus Functions as a Lung Cancer Suppressor by Binding Wnt3a to Inhibit Wnt/β-Catenin Signaling.

Xianglin Zuo, Xuchun Wang, Tingzheng Ma

|Jun 28, 2023
Enhanced Detection of Landmark Minimal Residual Disease in Lung Cancer Using Cell-free DNA Fragmentomics.

Siwei Wang, Zhijun Xia, Jing You

Pageof 1

Frequent Collaborators

1 joint publications

Siwei Wang

1 joint publications

Zhijun Xia

1 joint publications

Jing You

1 joint publications

Xiaolan Gu